88 related articles for article (PubMed ID: 2174150)
1. Antigenic profile of mammary fibroadenoma and cystosarcoma phyllodes. A study using antibodies to estrogen- and progesterone receptors and to a panel of cell surface molecules.
Mechtersheimer G; Krüger KH; Born IA; Möller P
Pathol Res Pract; 1990 Aug; 186(4):427-38. PubMed ID: 2174150
[TBL] [Abstract][Full Text] [Related]
2. Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but lack estrogen receptor: stromal localization of progesterone receptor.
Rao BR; Meyer JS; Fry CG
Cancer; 1981 Apr; 47(8):2016-21. PubMed ID: 6261932
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC
Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes.
Alberti O; Brentani MM; Goes JC; Lemos LB; Torloni H
Cancer; 1986 Mar; 57(5):1042-5. PubMed ID: 3002592
[TBL] [Abstract][Full Text] [Related]
5. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
6. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
7. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
Skasko E; Paszko Z; Mazur S
Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
Forti E; Wolf D; Melia M
Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
[No Abstract] [Full Text] [Related]
9. Expression of normal and tumor-associated antigens in human breast carcinoma.
Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
[TBL] [Abstract][Full Text] [Related]
10. Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression.
Santini D; Ceccarelli C; Taffurelli M; Pileri S; Marrano D
J Pathol; 1996 Aug; 179(4):386-91. PubMed ID: 8869285
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
12. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
14. Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas.
Vollmer G; Gerdes J; Knuppen R
Cancer Res; 1989 Jul; 49(14):4011-4. PubMed ID: 2736540
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
16. Steroid receptors in cystosarcoma phyllodes.
Brentani MM; Nagai MA; Oshima CT; Pacheco MM; Góes JC; Lemos LB
Cancer Detect Prev; 1982; 5(2):211-9. PubMed ID: 6290062
[TBL] [Abstract][Full Text] [Related]
17. Stromal proliferations of the breast: an ultrastructural and immunohistochemical evaluation of cystosarcoma phyllodes, juvenile fibroadenoma, and fibroadenoma.
Reddick RL; Shin TK; Sawhney D; Siegal GP
Hum Pathol; 1987 Jan; 18(1):45-9. PubMed ID: 2434405
[TBL] [Abstract][Full Text] [Related]
18. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
Hendler FJ; Yuan D
Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary and pancreatic mucinous cystadenocarcinomas with mesenchymal stroma: analysis of estrogen receptors/progesterone receptors and expression of tumor-associated antigens.
Weihing RR; Shintaku IP; Geller SA; Petrovic LM
Mod Pathol; 1997 Apr; 10(4):372-9. PubMed ID: 9110301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
